nodes	percent_of_prediction	percent_of_DWPC	metapath
Guanfacine—CYP3A4—Thiotepa—sarcoma	0.1	0.458	CbGbCtD
Guanfacine—CYP3A4—Mitoxantrone—sarcoma	0.0431	0.197	CbGbCtD
Guanfacine—CYP3A4—Vincristine—sarcoma	0.0297	0.136	CbGbCtD
Guanfacine—CYP3A4—Etoposide—sarcoma	0.0272	0.124	CbGbCtD
Guanfacine—NISCH—Podofilox—Etoposide—sarcoma	0.0213	0.592	CbGdCrCtD
Guanfacine—CYP3A4—Doxorubicin—sarcoma	0.0185	0.0847	CbGbCtD
Guanfacine—NISCH—Vinblastine—Vincristine—sarcoma	0.0147	0.408	CbGdCrCtD
Guanfacine—Decreased appetite—Thiotepa—sarcoma	0.00226	0.00303	CcSEcCtD
Guanfacine—Dermatitis exfoliative—Epirubicin—sarcoma	0.00226	0.00303	CcSEcCtD
Guanfacine—Oedema—Mitoxantrone—sarcoma	0.00225	0.00301	CcSEcCtD
Guanfacine—Decreased appetite—Dactinomycin—sarcoma	0.00224	0.00301	CcSEcCtD
Guanfacine—Fatigue—Thiotepa—sarcoma	0.00224	0.00301	CcSEcCtD
Guanfacine—Dysgeusia—Etoposide—sarcoma	0.00224	0.00301	CcSEcCtD
Guanfacine—Hyperhidrosis—Vincristine—sarcoma	0.00223	0.00299	CcSEcCtD
Guanfacine—Fatigue—Dactinomycin—sarcoma	0.00222	0.00299	CcSEcCtD
Guanfacine—Constipation—Thiotepa—sarcoma	0.00222	0.00298	CcSEcCtD
Guanfacine—Purpura—Epirubicin—sarcoma	0.00221	0.00297	CcSEcCtD
Guanfacine—Shock—Mitoxantrone—sarcoma	0.00221	0.00296	CcSEcCtD
Guanfacine—Vascular purpura—Doxorubicin—sarcoma	0.0022	0.00296	CcSEcCtD
Guanfacine—Muscle spasms—Etoposide—sarcoma	0.0022	0.00295	CcSEcCtD
Guanfacine—Tachycardia—Mitoxantrone—sarcoma	0.00219	0.00294	CcSEcCtD
Guanfacine—Cerebrovascular accident—Epirubicin—sarcoma	0.00217	0.00292	CcSEcCtD
Guanfacine—Lethargy—Epirubicin—sarcoma	0.00217	0.00292	CcSEcCtD
Guanfacine—Cardiac failure congestive—Doxorubicin—sarcoma	0.00217	0.00292	CcSEcCtD
Guanfacine—Hyperhidrosis—Mitoxantrone—sarcoma	0.00217	0.00291	CcSEcCtD
Guanfacine—Hypotension—Vincristine—sarcoma	0.00215	0.00289	CcSEcCtD
Guanfacine—Feeling abnormal—Thiotepa—sarcoma	0.00214	0.00288	CcSEcCtD
Guanfacine—Renal failure acute—Doxorubicin—sarcoma	0.00213	0.00286	CcSEcCtD
Guanfacine—Pain in extremity—Epirubicin—sarcoma	0.00213	0.00286	CcSEcCtD
Guanfacine—Feeling abnormal—Dactinomycin—sarcoma	0.00213	0.00285	CcSEcCtD
Guanfacine—Gastrointestinal pain—Thiotepa—sarcoma	0.00213	0.00285	CcSEcCtD
Guanfacine—Ill-defined disorder—Etoposide—sarcoma	0.00212	0.00285	CcSEcCtD
Guanfacine—Gastrointestinal pain—Dactinomycin—sarcoma	0.00211	0.00283	CcSEcCtD
Guanfacine—Musculoskeletal discomfort—Vincristine—sarcoma	0.0021	0.00282	CcSEcCtD
Guanfacine—Hypotension—Mitoxantrone—sarcoma	0.0021	0.00282	CcSEcCtD
Guanfacine—Affect lability—Epirubicin—sarcoma	0.0021	0.00281	CcSEcCtD
Guanfacine—Dermatitis exfoliative—Doxorubicin—sarcoma	0.00209	0.0028	CcSEcCtD
Guanfacine—Insomnia—Vincristine—sarcoma	0.00209	0.0028	CcSEcCtD
Guanfacine—Paraesthesia—Vincristine—sarcoma	0.00207	0.00278	CcSEcCtD
Guanfacine—Malaise—Etoposide—sarcoma	0.00206	0.00277	CcSEcCtD
Guanfacine—Vertigo—Etoposide—sarcoma	0.00206	0.00276	CcSEcCtD
Guanfacine—Abdominal pain—Thiotepa—sarcoma	0.00206	0.00276	CcSEcCtD
Guanfacine—Musculoskeletal discomfort—Mitoxantrone—sarcoma	0.00205	0.00275	CcSEcCtD
Guanfacine—Purpura—Doxorubicin—sarcoma	0.00204	0.00274	CcSEcCtD
Guanfacine—Abdominal pain—Dactinomycin—sarcoma	0.00204	0.00274	CcSEcCtD
Guanfacine—Paraesthesia—Mitoxantrone—sarcoma	0.00202	0.00271	CcSEcCtD
Guanfacine—Loss of consciousness—Etoposide—sarcoma	0.00201	0.0027	CcSEcCtD
Guanfacine—Lethargy—Doxorubicin—sarcoma	0.00201	0.0027	CcSEcCtD
Guanfacine—Cerebrovascular accident—Doxorubicin—sarcoma	0.00201	0.0027	CcSEcCtD
Guanfacine—Decreased appetite—Vincristine—sarcoma	0.002	0.00269	CcSEcCtD
Guanfacine—Dyspnoea—Mitoxantrone—sarcoma	0.002	0.00269	CcSEcCtD
Guanfacine—Somnolence—Mitoxantrone—sarcoma	0.002	0.00268	CcSEcCtD
Guanfacine—Fatigue—Vincristine—sarcoma	0.00199	0.00267	CcSEcCtD
Guanfacine—Convulsion—Etoposide—sarcoma	0.00198	0.00266	CcSEcCtD
Guanfacine—Dyspepsia—Mitoxantrone—sarcoma	0.00198	0.00265	CcSEcCtD
Guanfacine—Hypertension—Etoposide—sarcoma	0.00198	0.00265	CcSEcCtD
Guanfacine—Constipation—Vincristine—sarcoma	0.00197	0.00265	CcSEcCtD
Guanfacine—Pain in extremity—Doxorubicin—sarcoma	0.00197	0.00265	CcSEcCtD
Guanfacine—Liver function test abnormal—Epirubicin—sarcoma	0.00197	0.00264	CcSEcCtD
Guanfacine—Decreased appetite—Mitoxantrone—sarcoma	0.00195	0.00262	CcSEcCtD
Guanfacine—Chest pain—Etoposide—sarcoma	0.00195	0.00261	CcSEcCtD
Guanfacine—Abdominal pain upper—Epirubicin—sarcoma	0.00195	0.00261	CcSEcCtD
Guanfacine—Orthostatic hypotension—Epirubicin—sarcoma	0.00195	0.00261	CcSEcCtD
Guanfacine—Affect lability—Doxorubicin—sarcoma	0.00194	0.0026	CcSEcCtD
Guanfacine—Fatigue—Mitoxantrone—sarcoma	0.00194	0.0026	CcSEcCtD
Guanfacine—Discomfort—Etoposide—sarcoma	0.00192	0.00258	CcSEcCtD
Guanfacine—Constipation—Mitoxantrone—sarcoma	0.00192	0.00258	CcSEcCtD
Guanfacine—Hypersensitivity—Thiotepa—sarcoma	0.00192	0.00257	CcSEcCtD
Guanfacine—Hypersensitivity—Dactinomycin—sarcoma	0.0019	0.00255	CcSEcCtD
Guanfacine—Gastrointestinal pain—Vincristine—sarcoma	0.00189	0.00253	CcSEcCtD
Guanfacine—Confusional state—Etoposide—sarcoma	0.00188	0.00253	CcSEcCtD
Guanfacine—Alanine aminotransferase increased—Epirubicin—sarcoma	0.00188	0.00252	CcSEcCtD
Guanfacine—Asthenia—Thiotepa—sarcoma	0.00187	0.0025	CcSEcCtD
Guanfacine—Asthenia—Dactinomycin—sarcoma	0.00185	0.00248	CcSEcCtD
Guanfacine—Feeling abnormal—Mitoxantrone—sarcoma	0.00185	0.00248	CcSEcCtD
Guanfacine—Dysphagia—Epirubicin—sarcoma	0.00184	0.00247	CcSEcCtD
Guanfacine—Asthma—Epirubicin—sarcoma	0.00184	0.00247	CcSEcCtD
Guanfacine—Pruritus—Thiotepa—sarcoma	0.00184	0.00247	CcSEcCtD
Guanfacine—Gastrointestinal pain—Mitoxantrone—sarcoma	0.00184	0.00246	CcSEcCtD
Guanfacine—Tachycardia—Etoposide—sarcoma	0.00182	0.00245	CcSEcCtD
Guanfacine—Abdominal pain—Vincristine—sarcoma	0.00182	0.00245	CcSEcCtD
Guanfacine—Liver function test abnormal—Doxorubicin—sarcoma	0.00182	0.00244	CcSEcCtD
Guanfacine—Hyperhidrosis—Etoposide—sarcoma	0.00181	0.00242	CcSEcCtD
Guanfacine—Orthostatic hypotension—Doxorubicin—sarcoma	0.0018	0.00242	CcSEcCtD
Guanfacine—Abdominal pain upper—Doxorubicin—sarcoma	0.0018	0.00242	CcSEcCtD
Guanfacine—Diarrhoea—Thiotepa—sarcoma	0.00178	0.00239	CcSEcCtD
Guanfacine—Abdominal pain—Mitoxantrone—sarcoma	0.00177	0.00238	CcSEcCtD
Guanfacine—Diarrhoea—Dactinomycin—sarcoma	0.00177	0.00237	CcSEcCtD
Guanfacine—Hypotension—Etoposide—sarcoma	0.00175	0.00234	CcSEcCtD
Guanfacine—Alanine aminotransferase increased—Doxorubicin—sarcoma	0.00174	0.00233	CcSEcCtD
Guanfacine—Dizziness—Thiotepa—sarcoma	0.00172	0.00231	CcSEcCtD
Guanfacine—Asthma—Doxorubicin—sarcoma	0.0017	0.00229	CcSEcCtD
Guanfacine—Dysphagia—Doxorubicin—sarcoma	0.0017	0.00229	CcSEcCtD
Guanfacine—Pollakiuria—Epirubicin—sarcoma	0.0017	0.00228	CcSEcCtD
Guanfacine—Hypersensitivity—Vincristine—sarcoma	0.0017	0.00228	CcSEcCtD
Guanfacine—Paraesthesia—Etoposide—sarcoma	0.00168	0.00225	CcSEcCtD
Guanfacine—Weight increased—Epirubicin—sarcoma	0.00168	0.00225	CcSEcCtD
Guanfacine—Dyspnoea—Etoposide—sarcoma	0.00167	0.00223	CcSEcCtD
Guanfacine—Somnolence—Etoposide—sarcoma	0.00166	0.00223	CcSEcCtD
Guanfacine—Hypersensitivity—Mitoxantrone—sarcoma	0.00165	0.00222	CcSEcCtD
Guanfacine—Asthenia—Vincristine—sarcoma	0.00165	0.00222	CcSEcCtD
Guanfacine—Vomiting—Thiotepa—sarcoma	0.00165	0.00222	CcSEcCtD
Guanfacine—Drowsiness—Epirubicin—sarcoma	0.00164	0.0022	CcSEcCtD
Guanfacine—Vomiting—Dactinomycin—sarcoma	0.00164	0.0022	CcSEcCtD
Guanfacine—Rash—Thiotepa—sarcoma	0.00164	0.0022	CcSEcCtD
Guanfacine—Dermatitis—Thiotepa—sarcoma	0.00164	0.0022	CcSEcCtD
Guanfacine—Headache—Thiotepa—sarcoma	0.00163	0.00219	CcSEcCtD
Guanfacine—Rash—Dactinomycin—sarcoma	0.00163	0.00218	CcSEcCtD
Guanfacine—Decreased appetite—Etoposide—sarcoma	0.00162	0.00218	CcSEcCtD
Guanfacine—Asthenia—Mitoxantrone—sarcoma	0.00161	0.00216	CcSEcCtD
Guanfacine—Fatigue—Etoposide—sarcoma	0.00161	0.00216	CcSEcCtD
Guanfacine—Constipation—Etoposide—sarcoma	0.0016	0.00214	CcSEcCtD
Guanfacine—Conjunctivitis—Epirubicin—sarcoma	0.0016	0.00214	CcSEcCtD
Guanfacine—Diarrhoea—Vincristine—sarcoma	0.00158	0.00212	CcSEcCtD
Guanfacine—Sweating—Epirubicin—sarcoma	0.00157	0.00211	CcSEcCtD
Guanfacine—Pollakiuria—Doxorubicin—sarcoma	0.00157	0.00211	CcSEcCtD
Guanfacine—Weight increased—Doxorubicin—sarcoma	0.00155	0.00208	CcSEcCtD
Guanfacine—Nausea—Thiotepa—sarcoma	0.00154	0.00207	CcSEcCtD
Guanfacine—Feeling abnormal—Etoposide—sarcoma	0.00154	0.00207	CcSEcCtD
Guanfacine—Diarrhoea—Mitoxantrone—sarcoma	0.00154	0.00206	CcSEcCtD
Guanfacine—Nausea—Dactinomycin—sarcoma	0.00153	0.00206	CcSEcCtD
Guanfacine—Gastrointestinal pain—Etoposide—sarcoma	0.00153	0.00205	CcSEcCtD
Guanfacine—Dizziness—Vincristine—sarcoma	0.00152	0.00205	CcSEcCtD
Guanfacine—Drowsiness—Doxorubicin—sarcoma	0.00152	0.00204	CcSEcCtD
Guanfacine—Bradycardia—Epirubicin—sarcoma	0.0015	0.00201	CcSEcCtD
Guanfacine—Rhinitis—Epirubicin—sarcoma	0.00148	0.00198	CcSEcCtD
Guanfacine—Abdominal pain—Etoposide—sarcoma	0.00148	0.00198	CcSEcCtD
Guanfacine—Conjunctivitis—Doxorubicin—sarcoma	0.00148	0.00198	CcSEcCtD
Guanfacine—Vomiting—Vincristine—sarcoma	0.00147	0.00197	CcSEcCtD
Guanfacine—Sweating—Doxorubicin—sarcoma	0.00146	0.00195	CcSEcCtD
Guanfacine—Rash—Vincristine—sarcoma	0.00145	0.00195	CcSEcCtD
Guanfacine—Dermatitis—Vincristine—sarcoma	0.00145	0.00195	CcSEcCtD
Guanfacine—Headache—Vincristine—sarcoma	0.00144	0.00194	CcSEcCtD
Guanfacine—Vomiting—Mitoxantrone—sarcoma	0.00143	0.00192	CcSEcCtD
Guanfacine—Visual impairment—Epirubicin—sarcoma	0.00142	0.00191	CcSEcCtD
Guanfacine—Rash—Mitoxantrone—sarcoma	0.00142	0.0019	CcSEcCtD
Guanfacine—Dermatitis—Mitoxantrone—sarcoma	0.00141	0.0019	CcSEcCtD
Guanfacine—Headache—Mitoxantrone—sarcoma	0.00141	0.00189	CcSEcCtD
Guanfacine—Bradycardia—Doxorubicin—sarcoma	0.00139	0.00186	CcSEcCtD
Guanfacine—Eye disorder—Epirubicin—sarcoma	0.00138	0.00185	CcSEcCtD
Guanfacine—Hypersensitivity—Etoposide—sarcoma	0.00138	0.00185	CcSEcCtD
Guanfacine—Tinnitus—Epirubicin—sarcoma	0.00137	0.00184	CcSEcCtD
Guanfacine—Nausea—Vincristine—sarcoma	0.00137	0.00184	CcSEcCtD
Guanfacine—Rhinitis—Doxorubicin—sarcoma	0.00137	0.00183	CcSEcCtD
Guanfacine—Asthenia—Etoposide—sarcoma	0.00134	0.0018	CcSEcCtD
Guanfacine—Nausea—Mitoxantrone—sarcoma	0.00133	0.00179	CcSEcCtD
Guanfacine—Immune system disorder—Epirubicin—sarcoma	0.00133	0.00179	CcSEcCtD
Guanfacine—Pruritus—Etoposide—sarcoma	0.00132	0.00177	CcSEcCtD
Guanfacine—Visual impairment—Doxorubicin—sarcoma	0.00131	0.00176	CcSEcCtD
Guanfacine—Alopecia—Epirubicin—sarcoma	0.0013	0.00175	CcSEcCtD
Guanfacine—Diarrhoea—Etoposide—sarcoma	0.00128	0.00171	CcSEcCtD
Guanfacine—Eye disorder—Doxorubicin—sarcoma	0.00127	0.00171	CcSEcCtD
Guanfacine—Tinnitus—Doxorubicin—sarcoma	0.00127	0.00171	CcSEcCtD
Guanfacine—Tension—Epirubicin—sarcoma	0.00126	0.00169	CcSEcCtD
Guanfacine—Dysgeusia—Epirubicin—sarcoma	0.00126	0.00169	CcSEcCtD
Guanfacine—Nervousness—Epirubicin—sarcoma	0.00125	0.00167	CcSEcCtD
Guanfacine—Dizziness—Etoposide—sarcoma	0.00123	0.00166	CcSEcCtD
Guanfacine—Muscle spasms—Epirubicin—sarcoma	0.00123	0.00166	CcSEcCtD
Guanfacine—Immune system disorder—Doxorubicin—sarcoma	0.00123	0.00165	CcSEcCtD
Guanfacine—Vision blurred—Epirubicin—sarcoma	0.00121	0.00162	CcSEcCtD
Guanfacine—Alopecia—Doxorubicin—sarcoma	0.0012	0.00162	CcSEcCtD
Guanfacine—Ill-defined disorder—Epirubicin—sarcoma	0.00119	0.0016	CcSEcCtD
Guanfacine—Vomiting—Etoposide—sarcoma	0.00119	0.00159	CcSEcCtD
Guanfacine—Agitation—Epirubicin—sarcoma	0.00118	0.00158	CcSEcCtD
Guanfacine—Rash—Etoposide—sarcoma	0.00118	0.00158	CcSEcCtD
Guanfacine—Dermatitis—Etoposide—sarcoma	0.00118	0.00158	CcSEcCtD
Guanfacine—Headache—Etoposide—sarcoma	0.00117	0.00157	CcSEcCtD
Guanfacine—Tension—Doxorubicin—sarcoma	0.00116	0.00156	CcSEcCtD
Guanfacine—Dysgeusia—Doxorubicin—sarcoma	0.00116	0.00156	CcSEcCtD
Guanfacine—Malaise—Epirubicin—sarcoma	0.00116	0.00155	CcSEcCtD
Guanfacine—Nervousness—Doxorubicin—sarcoma	0.00115	0.00155	CcSEcCtD
Guanfacine—Vertigo—Epirubicin—sarcoma	0.00115	0.00155	CcSEcCtD
Guanfacine—Syncope—Epirubicin—sarcoma	0.00115	0.00154	CcSEcCtD
Guanfacine—Muscle spasms—Doxorubicin—sarcoma	0.00114	0.00153	CcSEcCtD
Guanfacine—Palpitations—Epirubicin—sarcoma	0.00113	0.00152	CcSEcCtD
Guanfacine—Loss of consciousness—Epirubicin—sarcoma	0.00113	0.00151	CcSEcCtD
Guanfacine—Vision blurred—Doxorubicin—sarcoma	0.00112	0.0015	CcSEcCtD
Guanfacine—Convulsion—Epirubicin—sarcoma	0.00111	0.00149	CcSEcCtD
Guanfacine—Nausea—Etoposide—sarcoma	0.00111	0.00149	CcSEcCtD
Guanfacine—Hypertension—Epirubicin—sarcoma	0.00111	0.00149	CcSEcCtD
Guanfacine—Ill-defined disorder—Doxorubicin—sarcoma	0.0011	0.00148	CcSEcCtD
Guanfacine—Arthralgia—Epirubicin—sarcoma	0.00109	0.00147	CcSEcCtD
Guanfacine—Chest pain—Epirubicin—sarcoma	0.00109	0.00147	CcSEcCtD
Guanfacine—Myalgia—Epirubicin—sarcoma	0.00109	0.00147	CcSEcCtD
Guanfacine—Agitation—Doxorubicin—sarcoma	0.00109	0.00146	CcSEcCtD
Guanfacine—Anxiety—Epirubicin—sarcoma	0.00109	0.00146	CcSEcCtD
Guanfacine—Discomfort—Epirubicin—sarcoma	0.00108	0.00145	CcSEcCtD
Guanfacine—Malaise—Doxorubicin—sarcoma	0.00107	0.00144	CcSEcCtD
Guanfacine—Dry mouth—Epirubicin—sarcoma	0.00107	0.00143	CcSEcCtD
Guanfacine—Vertigo—Doxorubicin—sarcoma	0.00107	0.00143	CcSEcCtD
Guanfacine—Syncope—Doxorubicin—sarcoma	0.00106	0.00143	CcSEcCtD
Guanfacine—Confusional state—Epirubicin—sarcoma	0.00106	0.00142	CcSEcCtD
Guanfacine—Palpitations—Doxorubicin—sarcoma	0.00105	0.00141	CcSEcCtD
Guanfacine—Oedema—Epirubicin—sarcoma	0.00105	0.00141	CcSEcCtD
Guanfacine—Loss of consciousness—Doxorubicin—sarcoma	0.00104	0.0014	CcSEcCtD
Guanfacine—Shock—Epirubicin—sarcoma	0.00103	0.00138	CcSEcCtD
Guanfacine—Convulsion—Doxorubicin—sarcoma	0.00103	0.00138	CcSEcCtD
Guanfacine—Hypertension—Doxorubicin—sarcoma	0.00102	0.00138	CcSEcCtD
Guanfacine—Tachycardia—Epirubicin—sarcoma	0.00102	0.00137	CcSEcCtD
Guanfacine—Hyperhidrosis—Epirubicin—sarcoma	0.00101	0.00136	CcSEcCtD
Guanfacine—Myalgia—Doxorubicin—sarcoma	0.00101	0.00136	CcSEcCtD
Guanfacine—Arthralgia—Doxorubicin—sarcoma	0.00101	0.00136	CcSEcCtD
Guanfacine—Chest pain—Doxorubicin—sarcoma	0.00101	0.00136	CcSEcCtD
Guanfacine—Anxiety—Doxorubicin—sarcoma	0.00101	0.00135	CcSEcCtD
Guanfacine—Discomfort—Doxorubicin—sarcoma	0.000998	0.00134	CcSEcCtD
Guanfacine—Dry mouth—Doxorubicin—sarcoma	0.000988	0.00133	CcSEcCtD
Guanfacine—Hypotension—Epirubicin—sarcoma	0.000978	0.00131	CcSEcCtD
Guanfacine—Confusional state—Doxorubicin—sarcoma	0.000977	0.00131	CcSEcCtD
Guanfacine—Oedema—Doxorubicin—sarcoma	0.000969	0.0013	CcSEcCtD
Guanfacine—Musculoskeletal discomfort—Epirubicin—sarcoma	0.000954	0.00128	CcSEcCtD
Guanfacine—Shock—Doxorubicin—sarcoma	0.000953	0.00128	CcSEcCtD
Guanfacine—Insomnia—Epirubicin—sarcoma	0.000947	0.00127	CcSEcCtD
Guanfacine—Tachycardia—Doxorubicin—sarcoma	0.000945	0.00127	CcSEcCtD
Guanfacine—Paraesthesia—Epirubicin—sarcoma	0.00094	0.00126	CcSEcCtD
Guanfacine—Hyperhidrosis—Doxorubicin—sarcoma	0.000936	0.00126	CcSEcCtD
Guanfacine—Dyspnoea—Epirubicin—sarcoma	0.000933	0.00125	CcSEcCtD
Guanfacine—Somnolence—Epirubicin—sarcoma	0.000931	0.00125	CcSEcCtD
Guanfacine—Dyspepsia—Epirubicin—sarcoma	0.000922	0.00124	CcSEcCtD
Guanfacine—Decreased appetite—Epirubicin—sarcoma	0.00091	0.00122	CcSEcCtD
Guanfacine—Hypotension—Doxorubicin—sarcoma	0.000905	0.00121	CcSEcCtD
Guanfacine—Fatigue—Epirubicin—sarcoma	0.000903	0.00121	CcSEcCtD
Guanfacine—Constipation—Epirubicin—sarcoma	0.000895	0.0012	CcSEcCtD
Guanfacine—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.000883	0.00118	CcSEcCtD
Guanfacine—Insomnia—Doxorubicin—sarcoma	0.000876	0.00118	CcSEcCtD
Guanfacine—Paraesthesia—Doxorubicin—sarcoma	0.00087	0.00117	CcSEcCtD
Guanfacine—Dyspnoea—Doxorubicin—sarcoma	0.000864	0.00116	CcSEcCtD
Guanfacine—Feeling abnormal—Epirubicin—sarcoma	0.000863	0.00116	CcSEcCtD
Guanfacine—Somnolence—Doxorubicin—sarcoma	0.000861	0.00116	CcSEcCtD
Guanfacine—Gastrointestinal pain—Epirubicin—sarcoma	0.000856	0.00115	CcSEcCtD
Guanfacine—Dyspepsia—Doxorubicin—sarcoma	0.000853	0.00114	CcSEcCtD
Guanfacine—Decreased appetite—Doxorubicin—sarcoma	0.000842	0.00113	CcSEcCtD
Guanfacine—Fatigue—Doxorubicin—sarcoma	0.000835	0.00112	CcSEcCtD
Guanfacine—Constipation—Doxorubicin—sarcoma	0.000828	0.00111	CcSEcCtD
Guanfacine—Abdominal pain—Epirubicin—sarcoma	0.000828	0.00111	CcSEcCtD
Guanfacine—Feeling abnormal—Doxorubicin—sarcoma	0.000798	0.00107	CcSEcCtD
Guanfacine—Gastrointestinal pain—Doxorubicin—sarcoma	0.000792	0.00106	CcSEcCtD
Guanfacine—Hypersensitivity—Epirubicin—sarcoma	0.000771	0.00104	CcSEcCtD
Guanfacine—Abdominal pain—Doxorubicin—sarcoma	0.000766	0.00103	CcSEcCtD
Guanfacine—Asthenia—Epirubicin—sarcoma	0.000751	0.00101	CcSEcCtD
Guanfacine—Pruritus—Epirubicin—sarcoma	0.000741	0.000994	CcSEcCtD
Guanfacine—Diarrhoea—Epirubicin—sarcoma	0.000716	0.000961	CcSEcCtD
Guanfacine—Hypersensitivity—Doxorubicin—sarcoma	0.000714	0.000958	CcSEcCtD
Guanfacine—Asthenia—Doxorubicin—sarcoma	0.000695	0.000933	CcSEcCtD
Guanfacine—Dizziness—Epirubicin—sarcoma	0.000692	0.000929	CcSEcCtD
Guanfacine—Pruritus—Doxorubicin—sarcoma	0.000685	0.00092	CcSEcCtD
Guanfacine—Vomiting—Epirubicin—sarcoma	0.000666	0.000893	CcSEcCtD
Guanfacine—Diarrhoea—Doxorubicin—sarcoma	0.000663	0.000889	CcSEcCtD
Guanfacine—Rash—Epirubicin—sarcoma	0.00066	0.000886	CcSEcCtD
Guanfacine—Dermatitis—Epirubicin—sarcoma	0.000659	0.000885	CcSEcCtD
Guanfacine—Headache—Epirubicin—sarcoma	0.000656	0.00088	CcSEcCtD
Guanfacine—Dizziness—Doxorubicin—sarcoma	0.000641	0.00086	CcSEcCtD
Guanfacine—Nausea—Epirubicin—sarcoma	0.000622	0.000835	CcSEcCtD
Guanfacine—Vomiting—Doxorubicin—sarcoma	0.000616	0.000827	CcSEcCtD
Guanfacine—Rash—Doxorubicin—sarcoma	0.000611	0.00082	CcSEcCtD
Guanfacine—Dermatitis—Doxorubicin—sarcoma	0.00061	0.000819	CcSEcCtD
Guanfacine—Headache—Doxorubicin—sarcoma	0.000607	0.000814	CcSEcCtD
Guanfacine—Nausea—Doxorubicin—sarcoma	0.000575	0.000772	CcSEcCtD
